Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Over-the-counter analgesic use and COVID-19

There is no proven scientific evidence preventing the use of either paracetamol or ibuprofen in treating symptoms of COVID-19.

ibuprofen tablets

Routine NSAID use not associated with poorer outcomes in patients hospitalised with COVID-19

10 NOV 2020

Routine use of non-steroidal anti-inflammatory drugs might confer “modest” survival benefit for patients hospitalised with COVID-19 and is not associated with poorer outcomes, the results of a study published in the Journal of Clinical Medicine have suggested.

Important considerations when recommending ibuprofen

  • Consider a patient’s individual risk factors, including any history of cardiovascular and gastrointestinal illness or known renal impairment;
  • Recommend patients use the lowest effective dose of ibuprofen for the shortest duration necessary to control symptoms;
  • Patients who have been prescribed NSAIDs as a treatment for a long-term condition, such as arthritis, should be advised to keep taking these medicines as normal;
  • Adult patients who take low-dose 75mg aspirin regularly for prevention of heart attacks or for vascular disease should continue to do so;
  • Any suspected side effects from a medicine, including those purchased over-the-counter, should be reported via the Yellow Card Scheme.
  • Ibuprofen paracetamol packets

    Paracetamol or ibuprofen can be used to treat the symptoms of COVID-19, says NHS England

    20 APR 2020By

    The NHS has changed its advice on only taking paracetamol to treat the symptoms of COVID-19 and now says that patients can take either paracetamol or ibuprofen to self-medicate for symptoms such as fever or headache.

    ibuprofen paracetamol packets

    Medicines regulator and NICE to review evidence of impact of NSAIDs on COVID-19

    18 MAR 2020By

    The Committee of Human Medicines — an advisory body of the Medicines and Healthcare products Regulatory Agency — and the National Institute for Health and Care Excellence are to review the evidence on the impact of non-steroidal anti-inflammatory drugs on the severity of COVID-19 infection.


    Advice on NSAIDs and COVID-19

    17 MAR 2020

    RPS issues advice following news reports originating in France regarding the use of ibuprofen in patients with COVID-19

    Lloydspharmacy store

    'Unprecedented demand' for OTC painkillers as COVID-19 outbreak spreads

    13 MAR 2020By

    The owner of LloydsPharmacy has said there is “unprecedented demand” for over-the-counter painkillers as a result of the COVID-19 pandemic.

    Site powered by Webvision